Literature DB >> 20809402

[The ENETS and UICC TNM classification of neuroendocrine tumors of the gastrointestinal tract and the pancreas: comment].

G Klöppel1, G Rindi, A Perren, P Komminoth, D S Klimstra.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20809402     DOI： 10.1007/s00292-010-1385-z

Source DB:  PubMed          Journal:  Pathologe        ISSN： 0172-8113            Impact factor:   1.011


× No keyword cloud information.
  9 in total

1.  TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system.

Authors:  G Rindi; G Klöppel; A Couvelard; P Komminoth; M Körner; J M Lopes; A-M McNicol; O Nilsson; A Perren; A Scarpa; J-Y Scoazec; B Wiedenmann
Journal:  Virchows Arch       Date:  2007-08-03       Impact factor: 4.064

2.  Pathology reporting of neuroendocrine tumors: application of the Delphic consensus process to the development of a minimum pathology data set.

Authors:  David S Klimstra; Irvin R Modlin; N Volkan Adsay; Runjan Chetty; Vikram Deshpande; Mithat Gönen; Robert T Jensen; Mark Kidd; Matthew H Kulke; Ricardo V Lloyd; Cesar Moran; Steven F Moss; Kjell Oberg; Dermot O'Toole; Guido Rindi; Marie E Robert; Saul Suster; Laura H Tang; Chin-Yuan Tzen; Mary Kay Washington; Betram Wiedenmann; James Yao
Journal:  Am J Surg Pathol       Date:  2010-03       Impact factor: 6.394

3.  Pancreatic endocrine tumors: improved TNM staging and histopathological grading permit a clinically efficient prognostic stratification of patients.

Authors:  Aldo Scarpa; William Mantovani; Paola Capelli; Stefania Beghelli; Letizia Boninsegna; Rossella Bettini; Francesco Panzuto; Paolo Pederzoli; Gianfranco delle Fave; Massimo Falconi
Journal:  Mod Pathol       Date:  2010-03-19       Impact factor: 7.842

4.  Prognostic factors and survival in 324 patients with pancreatic endocrine tumor treated at a single institution.

Authors:  Sara Ekeblad; Britt Skogseid; Kristina Dunder; Kjell Oberg; Barbro Eriksson
Journal:  Clin Cancer Res       Date:  2008-12-01       Impact factor: 12.531

5.  Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors.

Authors:  Ulrich-Frank Pape; Henning Jann; Jacqueline Müller-Nordhorn; Angelina Bockelbrink; Uta Berndt; Stefan N Willich; Martin Koch; Christoph Röcken; Guido Rindi; Bertram Wiedenmann
Journal:  Cancer       Date:  2008-07-15       Impact factor: 6.860

6.  Clinical outcome and long-term survival in 118 consecutive patients with neuroendocrine tumours of the pancreas.

Authors:  L Fischer; J Kleeff; I Esposito; U Hinz; A Zimmermann; H Friess; M W Büchler
Journal:  Br J Surg       Date:  2008-05       Impact factor: 6.939

7.  Improved histologic and clinicopathologic criteria for prognostic evaluation of pancreatic endocrine tumors.

Authors:  Stefano La Rosa; Catherine Klersy; Silvia Uccella; Linda Dainese; Luca Albarello; Angelica Sonzogni; Claudio Doglioni; Carlo Capella; Enrico Solcia
Journal:  Hum Pathol       Date:  2008-08-20       Impact factor: 3.466

8.  WHO 2004 criteria and CK19 are reliable prognostic markers in pancreatic endocrine tumors.

Authors:  Anja M Schmitt; Martin Anlauf; Valentin Rousson; Sonja Schmid; Andreas Kofler; Florian Riniker; Juliane Bauersfeld; Andre Barghorn; Nicole M Probst-Hensch; Holger Moch; Philipp U Heitz; Guenter Kloeppel; Paul Komminoth; Aurel Perren
Journal:  Am J Surg Pathol       Date:  2007-11       Impact factor: 6.394

9.  TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system.

Authors:  G Rindi; G Klöppel; H Alhman; M Caplin; A Couvelard; W W de Herder; B Erikssson; A Falchetti; M Falconi; P Komminoth; M Körner; J M Lopes; A-M McNicol; O Nilsson; A Perren; A Scarpa; J-Y Scoazec; B Wiedenmann
Journal:  Virchows Arch       Date:  2006-09-12       Impact factor: 4.064
  9 in total
  5 in total

Review 1.  [Extent of resection for neuroendocrine tumors of the small intestine].

Authors:  T J Musholt
Journal:  Chirurg       Date:  2011-07       Impact factor: 0.955

2.  Association of autoimmune thyroid diseases, chronic atrophic gastritis and gastric carcinoid: experience from a single institution.

Authors:  C Castoro; R Le Moli; M L Arpi; M Tavarelli; G Sapuppo; L Frittitta; S Squatrito; G Pellegriti
Journal:  J Endocrinol Invest       Date:  2016-02-29       Impact factor: 4.256

Review 3.  [What is new in the pathology of pancreatic neuroendocrine tumors?].

Authors:  P Komminoth; A Perren
Journal:  Pathologe       Date:  2015-05       Impact factor: 1.011

Review 4.  [Neuroendocrine tumors of the duodenum and pancreas. Surgical strategy].

Authors:  L Fischer; A Mehrabi; M W Büchler
Journal:  Chirurg       Date:  2011-07       Impact factor: 0.955

5.  Streptozocin-Based Chemotherapy in Patients with Advanced Neuroendocrine Neoplasms--Predictive and Prognostic Markers for Treatment Stratification.

Authors:  Sebastian Krug; Michael Boch; Hanna Daniel; Wilhelm Nimphius; Daniela Müller; Patrick Michl; Anja Rinke; Thomas Matthias Gress
Journal:  PLoS One       Date:  2015-12-02       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.